Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Hematology | Oncology | Dermatology

Clinical Trials: Sezary Syndrome


A listing of clinical trials currently looking for volunteers to enroll in Sezary Syndrome studies. Click on the closest city to find more detailed information on a research study in your area.

California

Stanford : Stanford University School of Medicine

Pilot Study of Brentuximab Vedotin (SGN-35) in Patients With MF With Variable CD30 Expression Level

Stanford : Stanford University School of Medicine

Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

New York

New York : Memorial Sloan-Kettering Cancer Center

Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

Ohio

Columbus : Ohio State University Medical Center

Bortezomib and Azacitidine in Treating Patients With Relapsed or Refractory T-Cell Lymphoma

Pennsylvania

Philadelphia : Fox Chase Cancer Center

Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

Pittsburgh : University of Pittsburgh School of Medicine

Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

Texas

Houston : MD Anderson Cancer Center

A-dmDT390-bisFv (UCHT1) Immunotoxin Therapy for Patients With T-cell Diseases

Houston : MD Anderson Cancer Center

Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma

Temple : Scott and White Hospital and Clinic

A-dmDT390-bisFv (UCHT1) Immunotoxin Therapy for Patients With T-cell Diseases

Italy

Bologna : Ospedale Sant'Orsola - Policlinico Sant'Orsola

Pralatrexate and Bexarotene in Patients With Relapsed or Refractory Cutaneous T-cell Lymphoma